Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AZN – AstraZeneca PLC

Float Short %

0.17

Margin Of Safety %

-2

Put/Call OI Ratio

0.49

EPS Next Q Diff

EPS Last/This Y

2.29

EPS This/Next Y

0.56

Price

80.97

Target Price

93.17

Analyst Recom

1.4

Performance Q

15.75

Relative Volume

0.8

Beta

0.37

Ticker: AZN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25AZN72.640.440.19126126
2025-07-28AZN71.860.460.82121827
2025-07-29AZN73.960.470.60128181
2025-07-30AZN76.60.480.15132474
2025-07-31AZN73.080.470.84138910
2025-08-01AZN73.960.470.49140298
2025-08-04AZN74.60.440.84135059
2025-08-05AZN74.470.450.42136138
2025-08-06AZN73.60.450.39137332
2025-08-07AZN74.590.450.03138058
2025-08-08AZN73.540.480.41133027
2025-08-11AZN74.080.470.66124765
2025-08-12AZN75.350.480.25125499
2025-08-13AZN76.960.470.31126364
2025-08-14AZN78.480.481.20127550
2025-08-15AZN79.180.480.13127968
2025-08-18AZN79.120.470.37114031
2025-08-19AZN79.590.470.45116782
2025-08-20AZN80.530.480.27116842
2025-08-21AZN80.460.480.42117978
2025-08-22AZN80.970.491.06120396
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25AZN72.6614.25082.14.44
2025-07-28AZN71.8111.54758.74.44
2025-07-29AZN73.9811.55275.04.44
2025-07-30AZN76.5911.55141.84.44
2025-07-31AZN73.099.93260.84.54
2025-08-01AZN73.959.93872.64.54
2025-08-04AZN74.599.94649.44.54
2025-08-05AZN74.489.94502.74.54
2025-08-06AZN73.619.24435.24.56
2025-08-07AZN74.579.25061.24.56
2025-08-08AZN73.559.25034.24.56
2025-08-11AZN74.089.25075.44.56
2025-08-12AZN75.369.25187.94.56
2025-08-13AZN77.949.25714.64.56
2025-08-14AZN78.489.25752.34.56
2025-08-15AZN79.199.25042.64.56
2025-08-18AZN79.119.24902.34.56
2025-08-19AZN79.549.24767.84.56
2025-08-20AZN80.529.24947.14.56
2025-08-21AZN80.469.24715.74.56
2025-08-22AZN80.979.24743.14.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25AZN0.001.260.20
2025-07-28AZN0.001.250.20
2025-07-29AZN01.250.20
2025-07-30AZN01.250.20
2025-07-31AZN01.250.20
2025-08-01AZN01.250.20
2025-08-04AZN01.170.20
2025-08-05AZN01.170.20
2025-08-06AZN01.170.20
2025-08-07AZN01.170.20
2025-08-08AZN01.170.20
2025-08-11AZN01.150.20
2025-08-12AZN01.150.17
2025-08-13AZN01.150.17
2025-08-14AZN01.150.17
2025-08-15AZN01.150.17
2025-08-18AZN01.360.17
2025-08-19AZN0.001.360.17
2025-08-20AZN0.001.360.17
2025-08-21AZN0.001.360.17
2025-08-22AZN0.001.360.17
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.09

Avg. EPS Est. Current Quarter

1.14

Avg. EPS Est. Next Quarter

1.09

Insider Transactions

Institutional Transactions

1.36

Beta

0.37

Average Sales Estimate Current Quarter

14762

Average Sales Estimate Next Quarter

15375

Fair Value

79.36

Quality Score

92

Growth Score

95

Sentiment Score

79

Actual DrawDown %

7.7

Max Drawdown 5-Year %

-27.9

Target Price

93.17

P/E

30.37

Forward P/E

15.73

PEG

2.58

P/S

4.44

P/B

5.61

P/Free Cash Flow

21.84

EPS

2.67

Average EPS Est. Cur. Y​

4.56

EPS Next Y. (Est.)

5.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.71

Relative Volume

0.8

Return on Equity vs Sector %

-6.1

Return on Equity vs Industry %

-14.5

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

4743.1
Astrazeneca PLC
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 94300
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
stock quote shares AZN – AstraZeneca PLC Stock Price stock today
news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch AZN – AstraZeneca PLC yahoo finance google finance
stock history AZN – AstraZeneca PLC invest stock market
stock prices AZN premarket after hours
ticker AZN fair value insiders trading